Danske Bank A/S United Therapeutics Corp Transaction History

Danske Bank A/S

  • $1.95 Trillion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 19, 2025
BUY
$274.7 - $438.75 $4.39 Million - $7.02 Million
15,989 New
15,989 $6.7 Million
Q2 2025

Dec 18, 2025
SELL
$276.47 - $328.4 $7.22 Million - $8.57 Million
-26,103 Reduced 44.03%
33,181 $9.53 Million
Q1 2025

Dec 18, 2025
BUY
$304.42 - $380.78 $13.2 Million - $16.5 Million
43,295 Added 270.78%
59,284 $18.3 Million

Others Institutions Holding UTHR

# of Institutions
802
Shares Held
41.4M
Call Options Held
1.56M
Put Options Held
2.86M
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $21.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Danske Bank A/S Portfolio

Follow Danske Bank A/S and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Danske Bank A/S, based on Form 13F filings with the SEC.

News

Stay updated on Danske Bank A/S with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email